L. A. Arnold

1.1k total citations
22 papers, 848 citations indexed

About

L. A. Arnold is a scholar working on Clinical Biochemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, L. A. Arnold has authored 22 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Clinical Biochemistry, 10 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in L. A. Arnold's work include Metabolism and Genetic Disorders (11 papers), Amino Acid Enzymes and Metabolism (4 papers) and Biochemical and Molecular Research (4 papers). L. A. Arnold is often cited by papers focused on Metabolism and Genetic Disorders (11 papers), Amino Acid Enzymes and Metabolism (4 papers) and Biochemical and Molecular Research (4 papers). L. A. Arnold collaborates with scholars based in United States, Switzerland and Germany. L. A. Arnold's co-authors include Rajindar S. Sohal, William C. Orr, Κ. Hyland, Rajindar S. Sohal, Barbara H. Sohal, Keith Hyland, Thomas N. Chase, Pierre J. Blanchet, John Y. Fang and M. Maral Mouradian and has published in prestigious journals such as Neurology, Annals of Neurology and Free Radical Biology and Medicine.

In The Last Decade

L. A. Arnold

22 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. A. Arnold United States 14 320 222 205 176 174 22 848
E Lezi United States 17 729 2.3× 162 0.7× 93 0.5× 138 0.8× 586 3.4× 23 1.3k
Lúcia Maria Vieira de Almeida Brazil 18 513 1.6× 220 1.0× 125 0.6× 126 0.7× 224 1.3× 23 1.1k
Jorge Iván Castillo-Quan United Kingdom 15 406 1.3× 103 0.5× 31 0.2× 131 0.7× 400 2.3× 22 1.1k
Setsuko Kanai Japan 21 283 0.9× 291 1.3× 38 0.2× 53 0.3× 230 1.3× 61 1.2k
Maria Jose Perez J. Chile 17 635 2.0× 231 1.0× 58 0.3× 143 0.8× 483 2.8× 22 1.1k
Marwan Maalouf United States 9 422 1.3× 176 0.8× 177 0.9× 46 0.3× 678 3.9× 15 979
Manuel J. Bández Spain 10 318 1.0× 136 0.6× 24 0.1× 116 0.7× 219 1.3× 12 677
Mojtaba Golpich Malaysia 9 449 1.4× 216 1.0× 60 0.3× 153 0.9× 193 1.1× 11 841
Elizabeth Mueni Mutisya United States 3 447 1.4× 134 0.6× 93 0.5× 72 0.4× 367 2.1× 5 659
Banthit Chetsawang Thailand 18 356 1.1× 271 1.2× 21 0.1× 107 0.6× 200 1.1× 54 1.0k

Countries citing papers authored by L. A. Arnold

Since Specialization
Citations

This map shows the geographic impact of L. A. Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. A. Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. A. Arnold more than expected).

Fields of papers citing papers by L. A. Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. A. Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. A. Arnold. The network helps show where L. A. Arnold may publish in the future.

Co-authorship network of co-authors of L. A. Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of L. A. Arnold. A scholar is included among the top collaborators of L. A. Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. A. Arnold. L. A. Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Saunders‐Pullman, Rachel, Nenad Blau, Κ. Hyland, et al.. (2004). Phenylalanine loading as a diagnostic test for DRD: interpreting the utility of the test. Molecular Genetics and Metabolism. 83(3). 207–212. 25 indexed citations
3.
Pranzatelli, Michael R., Keith Hyland, Elizabeth D. Tate, et al.. (2004). Evidence of Cellular Immune Activation in Children With Opsoclonus-Myoclonus: Cerebrospinal Fluid Neopterin. Journal of Child Neurology. 19(12). 919–924. 21 indexed citations
4.
Hyland, Κ., et al.. (2004). Tetrahydrobiopterin deficiency and dopamine loss in a genetic mouse model of Lesch‐Nyhan disease. Journal of Inherited Metabolic Disease. 27(2). 165–178. 16 indexed citations
5.
Hyland, Keith, et al.. (2003). Thehph-1 mouse: A model for dominantly inherited GTP-cyclohydrolase deficiency. Annals of Neurology. 54(S6). S46–S48. 40 indexed citations
6.
Hyland, Keith & L. A. Arnold. (2002). Value of lumbar puncture in the diagnosis of infantile epilepsy and folinic acid-responsive seizures.. PubMed. 17 Suppl 3. 3S48–55; discussion 3S56. 15 indexed citations
7.
Hyland, Κ., Torbjoern G. Nygaard, Joel M. Trugman, et al.. (1999). Oral phenylalanine loading profiles in symptomatic and asymptomatic gene carriers with dopa‐responsive dystonia due to dominantly inherited GTP cyclohydrolase deficiency. Journal of Inherited Metabolic Disease. 22(3). 213–215. 12 indexed citations
8.
Blanchet, Pierre J., John Y. Fang, Κ. Hyland, et al.. (1999). Short-term effects of high-dose 17β-estradiol in postmenopausal PD patients. Neurology. 53(1). 91–91. 106 indexed citations
9.
Hyland, Keith & L. A. Arnold. (1999). Value of Lumbar Puncture in the Diagnosis of Genetic Metabolic Encephalopathies. Journal of Child Neurology. 14(1_suppl). S9–S15. 11 indexed citations
10.
Blanchet, Pierre J., Spiros Konitsiotis, Κ. Hyland, et al.. (1998). Chronic Exposure to MPTP as a Primate Model of Progressive Parkinsonism: A Pilot Study with a Free Radical Scavenger. Experimental Neurology. 153(2). 214–222. 21 indexed citations
11.
Loeffler, David A., Peter A. LeWitt, Paul Juneau, et al.. (1998). Time-dependent effects of levodopa on regional brain dopamine metabolism and lipid peroxidation. Brain Research Bulletin. 47(6). 663–667. 12 indexed citations
12.
Hyland, Κ., L. A. Arnold, & Joel M. Trugman. (1998). Defects of biopterin metabolism and biogenic amine biosynthesis: clinical diagnostic, and therapeutic aspects.. PubMed. 78. 301–8. 12 indexed citations
14.
Hyland, Κ., Julie S. Fryburg, E. Martina Bebin, et al.. (1997). Oral phenylalanine loading in dopa‐responsive dystonia. Neurology. 48(5). 1290–1297. 58 indexed citations
15.
Hyland, Κ., et al.. (1996). Tetrahydrobiopterin and Biogenic Amine Metabolism in the hph‐1 Mouse. Journal of Neurochemistry. 67(2). 752–759. 39 indexed citations
16.
Baughman, Robert P., et al.. (1994). Paranoid psychosis due to neurosarcoidosis.. PubMed. 11(1). 34–6. 24 indexed citations
17.
Orr, William C., L. A. Arnold, & Rajindar S. Sohal. (1992). Relationship between catalase activity, life span and some parameters associated with antioxidant defenses in Drosophila melanogaster. Mechanisms of Ageing and Development. 63(3). 287–296. 52 indexed citations
18.
Sohal, Rajindar S., L. A. Arnold, & William C. Orr. (1990). Effect of age on superoxide dismutase, catalase, glutathione reductase, inorganic peroxides, TBA-reactive material, GSH/GSSG, NADPH/NADP+ and NADH/NAD+ in Drosophila melanogaster. Mechanisms of Ageing and Development. 56(3). 223–235. 155 indexed citations
19.
Sohal, Rajindar S., L. A. Arnold, & Barbara H. Sohal. (1990). Age-related changes in antioxidant enzymes and prooxidant generation in tissues of the rat with special reference to parameters in two insect species. Free Radical Biology and Medicine. 9(6). 495–500. 153 indexed citations
20.
Rákóczi, I., et al.. (1975). Effect of Heparin on Antithrombin III Activity During Delivery and Early Puerperium. Thrombosis and Haemostasis. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026